The purpose of this article is to inform readers about technical challenges that we encountered when assembling exome sequencing data from the Simplifying Complex Exomes (SIMPLEXO) consortium-whose mandate is the discovery of novel genes predisposing to breast and ovarian cancers. Our motivation is to share these obstacles-and our solutions to them-as a means of communicating important technical details that should be discussed early in projects involving massively parallel sequencing.